Atrovent and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Atrovent (ipratropium bromide), especially for people who are male, 40-49 old, also take Albuterol, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Hepatitis c when taking Atrovent. It is created by eHealthMe based on reports of 33,026 people who have side effects when taking Atrovent from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Jul, 14, 2026

33,026 people reported to have side effects when taking Atrovent.
Among them, 40 people (0.12%) have Hepatitis c.

Among these 40 people:

What is the gender of people who have Hepatitis c when taking Atrovent? *

female: 15 %
male: 85 %

What is the age of people who have Hepatitis c when taking Atrovent? *

What are other drugs people take besides Atrovent? *

What are other side effects people have besides Hepatitis c? *

Dizziness: 19 people, 47.50%
Chest Pain: 17 people, 42.50%
Weakness: 17 people, 42.50%
Headache (pain in head): 16 people, 40.00%
Depression: 15 people, 37.50%
Respiratory Depression (respiration has a rate below 12 breaths): 14 people, 35.00%
Confusional State: 14 people, 35.00%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 14 people, 35.00%
Testicular Pain (pain in testes): 14 people, 35.00%
Dehydration (dryness resulting from the removal of water): 14 people, 35.00%

What are the existing conditions these people have? *

High Blood Cholesterol: 9 people, 22.50%
Pain: 5 people, 12.50%
Osteoporosis (bones weak and more likely to break): 4 people, 10.00%
Dyspnea (difficult or laboured breathing): 3 people, 7.50%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 5.00%
High Blood Pressure: 2 people, 5.00%
Sleep Disorder: 1 person, 2.50%
Salivary Hypersecretion (excess saliva secretion): 1 person, 2.50%
Liver Transplant Rejection (failure of liver transplant): 1 person, 2.50%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atrovent:

Atrovent (33,210 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (787 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide (the active ingredients of Atrovent) and Atrovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.